Skip to main content

Table 1 IC50 and TI of free TNF, AuNPs, and AuNP-TNF in TZM-bl & PBMCs

From: Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept

Sr. No

Compound name

Anti–HIV1 assay TZM-bl cells

Anti–HIV1 assay PBMCs

IC50 HIV1VB28 (R5) (μg/mL)

TI

HIV1VB28 (R5)

IC50 HIV1UG070 (X4) (μg/mL)

TI

HIV1UG070 (X4)

IC50 HIV1VB28 (R5) (μg/mL)

TI

HIV1VB28

(R5)

IC50 HIV1UG070 (X4) (μg/mL)

TI

HIV1UG070

(X4)

1

TNF

0.771 ± 0.080

264.68

0.570 ± 0.196

358.29

0.394 ± 0.053

364.31 ± 30.48

0.560 ± 0.083

255.35 ± 5.19

2

AuNPs

1.745 ± 0.187

149.12

2.427 ± 0.079

107.20

1.171 ± 0.067

196.23 ± 8.32

0.1993 ± 0.039

115.01 ± 3.6

3

AuNP-TNF

0.026 ± 0.005

15,178.53 (***)

0.037 ± 0.008

10,796.86 (***)

0.016 ± 0.004

22,897.63 ± 6375.34 (***)

0.030 ± 0.005

11,332.61 ± 2198.59 (***)

  1. *** denotes p≤0.0001, the significant difference is in comparison with the drug control, TNF